Amplification of MDM2 inhibits MyoD-mediated myogenesis.
about
Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrestThe Mdm2 oncoprotein interacts with the cell fate regulator NumbA TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback controlThe MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoterHuman rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.Global transcriptional characterization of SP and MP cells from the myogenic C2C12 cell line: effect of FGF6.Mdm2: the ups and downs.Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.Delayed replication timing leads to delayed mitotic chromosome condensation and chromosomal instability of chromosome translocations.pRB induces Sp1 activity by relieving inhibition mediated by MDM2.MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.Mdm2 promotes myogenesis through the ubiquitination and degradation of CCAAT/enhancer-binding protein β.Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage.Nutlin-3 down-regulates retinoblastoma protein expression and inhibits muscle cell differentiation.A repertoire of cell cycle regulators whose expression is coordinated with human cytotrophoblast differentiationMyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state.Myogenic regulatory transcription factors regulate growth in rhabdomyosarcomaMdm2 and MdmX as Regulators of Gene ExpressionProof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma.Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters.Proteolytic cleavage of the mdm2 oncoprotein during apoptosis.Mdm2 controls CREB-dependent transactivation and initiation of adipocyte differentiation.Regulation of differentiation by HBP1, a target of the retinoblastoma protein.The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation.Differentiation of rhabdomyosarcoma cell lines using retinoic acid.Regulation of MyoD activity and muscle cell differentiation by MDM2, pRb, and Sp1.p53 is phosphorylated at the carboxyl terminus and promotes the differentiation of human HaCaT keratinocytes.P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines.MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice.p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol.
P2860
Q24317123-9F5BDB30-0580-40E3-85DA-C5AF4F178F28Q24522545-9371AA9D-685E-4DD6-902C-F356BF418E31Q24621472-54E9B17C-9FBA-4D82-9F22-178BA5A51FE9Q28255693-84C2BD1B-E6AB-4875-BC70-1EE0B349A797Q30418118-A9312E37-5C0D-4FB9-AED9-DEB1C86B8039Q33220010-DC299662-C178-4E91-B78F-CDF1E7B283C9Q33594040-95D50EFE-E297-4CF7-A5AA-B26A66666E54Q33888123-36C72F62-E3FD-4C42-91FF-6DE92DBF3922Q33949329-51ECE296-95DD-4865-B92A-F6E912DC9048Q34446511-A3FCB9D6-9B19-45C0-B9D6-673CA8D48CE6Q34489720-23005B9D-38E3-4927-9AD0-C437304781FDQ35451059-3A946FB3-3058-45D9-823F-43660228E1DAQ35671727-A7F05111-183E-4A47-B9D7-6047B062775CQ35681140-DC29A926-68DD-48A7-898E-AEE0F1124BD5Q35745811-32214DF0-682A-48E8-8825-45BC3388D0D8Q37141809-BB0DF00D-3D80-41F4-A795-877DCAC14706Q37583178-34F1D30F-CE29-4DFF-9E77-4E5C8A05ABAAQ38059700-19C61400-0188-4C59-9655-EE95B50BA8CDQ38105879-2483F5CD-4E72-4067-A536-25AA3A705E27Q38316452-DDA9A30B-D9B5-4D73-999A-4EECBC04E4B4Q38343171-965705CB-5769-4BB7-B6EB-60B35F34FB8BQ39386085-57891608-E929-4EEA-8C41-A2679A03743AQ39575606-846003EC-B0B7-4510-8C3D-12907045E0E1Q40233567-DB85050F-70C0-42B1-ACCC-8F081877159AQ40352092-38FC0E86-D56E-4614-B3AB-EE8D2FE7E0E7Q40654194-8DB39FA4-0300-40FA-B915-17AADD71F5B1Q40828469-C232C849-ECBE-4F19-A10D-B9544F077433Q40864851-682A9B87-6693-47D5-8A20-7B602C63BF80Q42468494-521BA734-04BF-43D4-A8C1-3CED2153B716Q52534736-B976FB7E-580C-468C-87FC-3659FBA820C7Q53424981-67F37013-63B2-4575-9871-5910A17E780A
P2860
Amplification of MDM2 inhibits MyoD-mediated myogenesis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Amplification of MDM2 inhibits MyoD-mediated myogenesis.
@en
type
label
Amplification of MDM2 inhibits MyoD-mediated myogenesis.
@en
prefLabel
Amplification of MDM2 inhibits MyoD-mediated myogenesis.
@en
P2093
P2860
P356
P1476
Amplification of MDM2 inhibits MyoD-mediated myogenesis.
@en
P2093
M J Thayer
S J Tapscott
T A Fiddler
P2860
P304
P356
10.1128/MCB.16.9.5048
P407
P577
1996-09-01T00:00:00Z